About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Texas | 864 Studies

Clinical Trials Prostate CancerTexas

Prostate Cancer Clinical Trials in Texas

Find 864 clinical trials for prostate cancer near Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 481-500 of 864 trials

Active not recruitingA Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsThe purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.NCT05787587·Phoenix, Arizona and 26 others CompletedObservational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate CancerObservational study in the routine clinical practice setting to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer…NCT02141438·Anchorage, Alaska and 67 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedFinasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing SurgeryThis randomized phase II trial studies how well finasteride works in treating patients with stage II prostate cancer who are undergoing surgery.NCT00438464·Cleveland, Ohio and 7 others

Completed64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)The aim of this study is to determine the safety and efficacy of 64Cu-SAR-BBN and determine the ability of 64Cu-SAR-BBN Positron emission tomography (PET)/computed tomography (CT)…NCT05407311·Los Angeles, California and 7 others

TerminatedExtension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsParticipants responding well in Study FE200486 CS06 (NCT00117949) were given the opportunity to continue treatment with degarelix under a clinical study until FE200486 was…NCT00117312·Anaheim, California and 11 others

RecruitingThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)The Phase 2 monotherapy portion of this study is currently enrolling and will evaluate the efficacy and safety of PC14586 (INN rezatapopt) in participants with locally advanced or…NCT04585750·Irvine, California and 75 others

RecruitingAdjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical ProstatectomyThis is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival.NCT02064673·Dallas, Texas

TerminatedA Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsThe purpose of the trial is to evaluate the safety, determine the recommended Phase 2 dose (RP2D), and assess preliminary clinical activity of GEN1044 in patients with solid…NCT04424641·Nashville, Tennessee and 5 others

RecruitingA Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.This study will explore whether a combination of the investigational drug PF-06821497 and enzalutamide will work better than taking enzalutamide alone in participants with mCRPC…NCT06629779·Chandler, Arizona and 230 others

CompletedA Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerThe purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from…NCT01322490·Anchorage, Alaska and 219 others

CompletedOpen Label Study of Sipuleucel-T in Metastatic Prostate CancerThis is a Multicenter, Open Label, Phase 2 Study of Sipuleucel-T in Men with Metastatic Castrate Resistant Prostate Cancer (CRPC).NCT00901342·Washington D.C., District of Columbia and 17 others

TerminatedDovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)The goal of this clinical research study is to learn if adding dovitinib to the combination of abiraterone acetate and prednisone may help to control metastatic CRPC.NCT01994590·Houston, Texas

CompletedStereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesRATIONALE: Stereotactic radiation therapy can send x-rays directly to the tumor and cause less damage to normal tissue.NCT00377156·Phoenix, Arizona and 63 others

RecruitingGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate CancerThe objective of this study is to see if providing an appropriate therapy based on the genomic testing of prostate tumour tissue will result in an improved clinical response.NCT04812366·Sacramento, California and 8 others

RecruitingA Study of MGC026 in Participants With Advanced Solid TumorsThe study is designed to understand the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of vobramitamab tavatecan (MGC026) in…NCT06242470·Los Angeles, California and 11 others

Active not recruitingConventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate CancerThis phase III trial studies how well hypofractionated radiation therapy works compared to the conventional one in treating patients with prostate cancer.NCT03987386·Houston, Texas and 2 others

TerminatedSafety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate CancerThis study will be conducted in three parts.NCT02349139·Los Angeles, California and 5 others

CompletedPROCLAIM: Germline Genetic Testing for Prostate Cancer PatientsThis registry is for men who have prostate cancer and have had multigene panel hereditary testing.NCT05447637·San Diego, California and 18 others

CompletedA Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate CancerThe purpose of this study is to determine whether IMC-A12 or IMC-1121B (ramucirumab) with Mitoxantrone and Prednisone is effective in the treatment of metastatic androgen-…NCT00683475·La Jolla, California and 35 others

CompletedImaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer RecurrenceA prospective, Phase 3, multi center, single-arm, imaging study investigating the safety and diagnostic performance of rhPSMA 7.3 (18F) Positron Emission Tomography (PET) ligand…NCT04186845·Birmingham, Alabama and 27 others

PreviousPage 25 of 44Next

Other Conditions in Texas

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma